Welcome to Axentis Pharma

Axentis Pharma is a Swiss-based pharmaceutical company focused on chronic lung diseases and respiratory related disorders, especially on cystic fibrosis. The company developed ARB-CF0223, a nanocarrier-based drug delivery technology which received orphan designations in Europe and in the USA. Axentis won a final and binding arbitral award which was issued by the Japan Commercial Arbitration Association (JCAA) in Tokyo in August 2013. Currently, Axentis is seeking to enforce the award through judicial remedies.

Meet us at
October 4-6, 2016
Barcelona, Spain
CPhI Worldwide
c/o Praxis und Kurszentrum Edith Aziz
Limmatquai 138
8001 Zurich

© 2014 Axentis Pharma AG Limmatquai 138, 8001 Zurich phone: +41 44 202 7878